We are live on ! Find out more
GH

GAM Holding Portfolio holdings

AUM $1.57B
1-Year Est. Return 25.73%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+25.73%
3 Year Est. Return
+139.18%
5 Year Est. Return
+157.55%
10 Year Est. Return
+644.43%
AUM
$2.15B
AUM Growth
+$463M
Cap. Flow
+$402M
Cap. Flow %
18.71%
Top 10 Hldgs %
22.96%
Holding
358
New
90
Increased
112
Reduced
93
Closed
43

Top Buys

Rank Stock Value
1
JD icon
JD.com
JD
+$41.2M
2
BIDU icon
Baidu
BIDU
+$32.3M
3
TME icon
Tencent Music
TME
+$28.2M
4
V icon
Visa
V
+$24.3M
5
MCFE
McAfee Corp. Class A Common Stock
MCFE
+$24.1M

Sector Composition

Rank Sector Weight
1 Technology 27.38%
2 Consumer Discretionary 19.24%
3 Communication Services 13.67%
4 Healthcare 13.53%
5 Financials 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALSK
201
DELISTED
Alaska Communications Systems
ALSK
$1.95M 0.09%
+601,000
New +$1.97M
HUM icon
202
Humana
HUM
$46.7B
$1.95M 0.09%
+4,640
New +$1.85M
IEMG icon
203
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
$1.92M 0.09%
29,900
NBIX icon
204
Neurocrine Biosciences
NBIX
$17.7B
$1.92M 0.09%
+19,704
New +$2.07M
INOV
205
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$1.88M 0.09%
65,232
+48,172
+282% +$1.24M
AMED
206
DELISTED
Amedisys
AMED
$1.75M 0.08%
6,627
+2,188
+49% +$617K
CUB
207
DELISTED
Cubic Corporation
CUB
$1.72M 0.08%
+23,100
New +$1.58M
BMRN icon
208
BioMarin Pharmaceuticals
BMRN
$11.5B
$1.72M 0.08%
+22,802
New +$1.86M
NEO icon
209
NeoGenomics
NEO
$1.81B
$1.69M 0.08%
+35,070
New +$1.83M
SYY icon
210
Sysco
SYY
$39.7B
$1.65M 0.08%
20,905
+10,155
+94% +$787K
REGN icon
211
Regeneron Pharmaceuticals
REGN
$68.8B
$1.64M 0.08%
+3,456
New +$1.68M
GPN icon
212
Global Payments
GPN
$22.1B
$1.59M 0.07%
7,883
+776
+11% +$155K
BILI icon
213
Bilibili
BILI
$7.18B
$1.54M 0.07%
+14,401
New +$1.76M
ALXN
214
PUT
DELISTED
Alexion Pharmaceuticals
ALXN
$1.53M 0.07%
+10,000
New +$1.55M
ZTO icon
215
ZTO Express
ZTO
$18.2B
$1.5M 0.07%
51,409
-6,223
-11% -$203K
RGNX icon
216
Regenxbio
RGNX
$623M
$1.47M 0.07%
+43,226
New +$1.84M
ILMN icon
217
Illumina
ILMN
$29.4B
$1.44M 0.07%
3,843
+1,594
+71% +$650K
DXCM icon
218
DexCom
DXCM
$27.6B
$1.42M 0.07%
15,752
+11,424
+264% +$1.07M
BP icon
219
BP
BP
$113B
$1.36M 0.06%
55,863
GNMK
220
DELISTED
GenMark Diagnostics, Inc
GNMK
$1.31M 0.06%
+55,000
New +$1.02M
PANW icon
221
Palo Alto Networks
PANW
$264B
$1.31M 0.06%
24,384
+3,492
+17% +$208K
MIK
222
DELISTED
Michaels Stores, Inc
MIK
$1.3M 0.06%
+59,300
New +$1.05M
KSU
223
DELISTED
Kansas City Southern
KSU
$1.29M 0.06%
4,887
+3,839
+366% +$835K
TCRR
224
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$1.29M 0.06%
+58,343
New +$1.59M
WTRE
225
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
$1.26M 0.06%
36,300

Similar funds

GAM Holding's Q1 2021 Portfolio in Review

As of Q1 2021, GAM Holding held 358 positions worth $2.15B, up 27% from $1.69B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

GAM Holding deployed $402M of net new capital in Q1 2021, opening 90 new positions and adding to 112 existing holdings. Its largest new stake was JD.com: 448,824 shares worth $37.8M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Farfetch Limited Class A Ordinary Shares, an estimated $12.6M trimmed.

  • GAM Holding's largest Q1 2021 buy was JD.com: 448,824 shares worth $37.8M.
  • GAM Holding added most to Baidu in Q1 2021, an estimated $32.3M increase.
  • GAM Holding's biggest Q1 2021 reduction was Farfetch Limited Class A Ordinary Shares, cutting an estimated $12.6M.
  • GAM Holding fully exited Strategy Inc in Q1 2021, selling an estimated $20.2M.
  • GAM Holding's ten largest holdings make up 23% of its $2.15B portfolio in Q1 2021.
  • GAM Holding opened 90 new positions and closed 43 in Q1 2021.
  • GAM Holding's portfolio value rose 27% quarter-over-quarter to $2.15B.

Based on GAM Holding's 13F filing for Q1 2021, filed 10 May 2021.